Infectious Diseases

< Back

Overview

The aim of the seven groups of this area is to improve the outcomes of patients with infectious diseases. The Epidemiology and Public Health group is mainly focused on the epidemiology and prevention of healthcare acquired infections, transmissible infections and on the new preventive vaccines. The Infectious Diseases group focuses on improving the strategies of clinical problems observed in clinical practice. Microbiology studies mechanisms of resistance to antimicrobials, pathogenicity, taxonomy and epidemiology, and infectious diseases diagnostics.

The CRIPS group focuses on the most prevalent aspects of infections in the intensive care unit (ICU), while SODIR group works in the areas of shock, organ dysfunction and resuscitation.

There is also a group focused on infection in immunocompromised pediatric patients, and a group from the CIBBIM-Nanomedicine interested in the synthesis, characterization and applications of engineered inorganic nanoparticles in the field of medicine.

Publications

108
total
876.949
impact factor
4.665
average impact factor

Group Leader: Victor Franco Puntes

In 2018 there have been important advances in the application of cerium oxide nanoparticles for the treatment of retinal diseases. The project has been funded by the Instituto Carlos III of the Spanish kingdom and we have started to write the patent. Regarding patents, the bi-functionalization of AuNPs to bring together AIDS infected T-cells and Natural Killer Cells. Also, we started to work in the frame-work of an Euronanomed H2020 project to produce NP based delivery of DNA or RNA, specially focusing on RNA for temporal CAR-T cell therapy. We also developed technological protocols to observe metal and metal oxide NPs in the confocal microscope in reflectance mode. Also, we started working on neuroinflammation targeting the epilepsy – neuroinflamation vicious loop in the context of neuronal channelopathies.

VHIR Annual Report 2018